MapLight Therapeutics, Inc. (MPLT)
7.58
-0.14
(-1.81%)
USD |
NASDAQ |
Oct 30, 16:00
7.65
+0.07
(+0.92%)
After-Hours: 20:00
MapLight Therapeutics Cash from Operations (Quarterly) : -44.87M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -44.87M |
| March 31, 2026 | -51.18M |
| December 31, 2025 | -46.83M |
| September 30, 2025 | -31.79M |
| June 30, 2025 | -33.97M |
| Date | Value |
|---|---|
| March 31, 2025 | -25.55M |
| June 30, 2024 | -17.53M |
| March 31, 2024 | -19.94M |
| March 31, 2023 | -11.98M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Cullinan Therapeutics, Inc. | -38.22M |
| Arrowhead Pharmaceuticals, Inc. | -177.47M |
| Oncolytics Biotech, Inc. | -8.066M |
| Sangamo Therapeutics, Inc. | -19.28M |
| Sarepta Therapeutics, Inc. | 197.07M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 60.70M |
| Cash from Financing (Quarterly) | 0.092M |
| Free Cash Flow | -175.12M |
| Free Cash Flow Per Share (Quarterly) | -0.9881 |
| Free Cash Flow to Equity (Quarterly) | -41.29M |
| Free Cash Flow to Firm (Quarterly) | -44.89M |
| Free Cash Flow Yield | -51.33% |